摘要
目的:研究血管内皮生长因子(vascular endothelial growth factor,VEGF)基因沉默对D-(-)-MTX/A549耐药细胞株迁移和侵袭的影响及可能的分子机制。方法:采用siRNA技术沉默D-(-)-MTX/A549耐药细胞株VEGF基因,细胞划痕试验和Transwell试验检测细胞迁移和侵袭能力,实时荧光定量PCR检测VEGF、MMP-2 mRNA,Western blot检测p-ERK1/2蛋白的表达。结果:VEGF siRNA序列及阴性对照成功转染至D-(-)-MTX/A549后,VEGF mRNA表达水平明显下降,与阴性对照相比下降了2.29倍,差异具有统计学意义(P=0.002),表明转染成功。阴性对照组与空白组差异无统计学意义(P>0.05)。转染后,D-(-)-MTX/A549迁移和侵袭能力明显下降(P值均<0.05),D-(-)-MTX/A549耐药细胞MMP-2 mRNA、p-ERK1/2的蛋白达也较阴性对照水平明显下降(P值均<0.05)。结论:抑制VEGF基因表达可以抑制D-(-)-MTX/A549细胞的迁移和侵袭能力,这一过程可能涉及到MMP-2和p-ERK1/2信号通路。
AIM: To study effects of silencing VEGF gene expression on migration and invasion of D-(-) -MTX/A549 resistance ceils. METHODS: VEGF siRNA was transfected to D-(-)-MTX/A549 resistance cells. Migration and invasion ablities were detected by scratch wound healing and transwell as- say respectively. The mRNA expression levels of VEGF and MMP-2 were examined by real-time fluo- rescent quantitative PCR. The protein expression level of p-ERK1/2 was detected by western blot a- nalysis. RESULTS:After VEGF siRNA and negative control were transfected to D- (-) - MTX/A549, VEGF mRNA expression level was decreased obvi- ously compared with negative control ( P = 0. 002 ),negative control and blank groups have no statistical significance (P 〉 0.05 ). D- (-) - MTX/A549 mi- gration and invasion ability significantly decreased (P 〈 0.05) ,MMP-2 mRNA and P-ERK1/2 protein levels were also significantly decreased after trans- fection (P 〈 0.05 ). CONCLUSION : Inhibition of VEGF expression can inhibit the D- (-) - MTX/ A549 cell migration and invasion ability, and this process may involve the MMP-2 and p-ERK1/2 sig- naling pathways.
出处
《中国临床药理学与治疗学》
CAS
CSCD
2016年第7期745-748,共4页
Chinese Journal of Clinical Pharmacology and Therapeutics
基金
安徽省高等学校省级自然科学研究基金(KJ2013B319)
皖南医学院重点科研项目培育基金项目(WK2013ZF04)
关键词
血管内皮生长因子
甲氨蝶呤
耐药
细胞迁移
细胞侵袭
vascular endothelial growth factor
methotrexate
resistance
cell migration
cell inva- sion